SMC and AWMSG call off meetings
To protect the health of stakeholders, and to ensure continuity of service, the Scottish Medicines Consortium (SMC) and the All-Wales … read more »
*Updated* NICE shifts focus as COVID-19 takes priority
The National Institute for Health and Care Excellence (NICE) has written to bodies such as the Ethical Medicines Industry Group … read more »
SMC announces November 2019 decisions
The Scottish Medicines Consortium (SMC) has published its medicine recommendations for November 2019 including a new combination breast cancer treatment. … read more »
EUnetHTA publishes REQueST Tool and its vision paper
EUnetHTA has published its Registry Evaluation and Quality Standards Tool (REQueST) and vision paper which aims to support HTA organisations … read more »
EUnetHTA announces public consultation on new methodological guidelines
EUnetHTA has launched a public consultation regarding new practical methodological guidelines for HTA assessors, particularly with respect to relative effectiveness … read more »
HTAi announces consultation on 2020-25 Strategic Plan
HTAi has launched a consultation of its members regarding its strategic goals, which will feed into its finalised plan due … read more »
EUnetHTA publish Summer Magazine 2019
EUnetHTA has released its latest magazine in a new interactive online format. In addition to an overview of EUnetHTA and … read more »
Report analyses hospital-based HTA
A recent report from The Research Insights provides analysis of the global hospital-based HTA market showing emerging trends and growth … read more »
Lords debate NICE charging for technology appraisals
Last night the House of Lords debated NICE charging for technology appraisals. During the debate, Lords raised concerns over the … read more »
Regulators Can Add Value to Novel Treatments Through “Evidence by Design”
Regulators can help in the assessment of added therapeutic benefit of novel therapies by explicit reasoning and “evidence by design” … read more »
